Navigation Links
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
Date:10/18/2007

one marrow and spleen, so selecting targets in these tissues is part of our strategy for developing effective drugs. We plan to move ISIS 388626 forward toward human proof-of-concept as rapidly as possible, and we look forward to continuing to populate our metabolic disease pipeline with drugs arising from our prolific research program."

ABOUT SGLT2 AND ISIS 388626

The sodium dependent glucose transporter type 2 (SGLT2) is substantially responsible for glucose re-absorption in the kidney. Decreasing SGLT2 function promotes glucose excretion to help reduce blood sugar levels, making it an attractive target for the treatment of diabetes. In preclinical studies, Isis has demonstrated in several animal species that ISIS 388626 and other antisense inhibitors of SGLT2 effectively reduce target mRNA levels, increase urinary glucose excretion and consequently lower blood glucose levels and HbA1c without causing dangerously low levels of blood sugar known as hypoglycemia. This is consistent with expectations based on human subjects who have mutations in the SGLT2 gene and have increased urine glucose levels but are otherwise asymptomatic. ISIS 388626 effectively and specifically inhibits the production of SGLT2 in the kidney tissue, without having any effect on a related gene product, SGLT1. In addition to being Isis' first second-generation antisense drug for a kidney target, ISIS 388626 is also unique due to its 12 nucleotide length rather than the more typical 18 - 21 nucleotide sequences that comprise Isis' other drugs. This attribute simplifies manufacturing and has the potential to substantially reduce related expenses. The short sequence may also contribute to ISIS 388626's unusually high potency; it is among the most potent antisense drugs Isis has yet evaluated in preclinical models.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The C
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Cancer drugs in development nearly doubled since 1995
3. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
4. Role of zinc in development
5. Particulate matter affects lung development
6. Fossil teeth and human development
7. High development costs hinder entry of cancer super drugs into the market
8. Fireflies help speed development of new drugs
9. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
10. New fertility drug development techniques by Organon
11. Biosensor chip to help drug development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Jose, California (PRWEB) September 30, 2014 ... are organic compounds, which are mixed with animal feed ... weight gain, and improve gut health and digestion. Amidst ... milk, eggs and meat across the globe, the need ... and aquaculture sectors is on the rise, thereby driving ...
(Date:9/30/2014)... Eastern Finland shows that dietary polyunsaturated fatty acids may ... of polyunsaturated fatty acids include fish, vegetable oils, and ... & Vascular Biology , an esteemed journal of the ... an association between the consumption of saturated fats and ... mere reduction of saturated fats from the diet does ...
(Date:9/30/2014)... Amy Norton ... News) -- Long-acting contraceptive devices should be the first ... from the American Academy of Pediatrics state. Although ... pills, two other forms of contraception -- intrauterine devices ... according to the academy. And they should be ...
(Date:9/30/2014)... Visit Pam and Steve’s quiet home in ... find a loving couple facing the most monumental challenge ... , Steve was diagnosed with ALS – more commonly ... before the couple’s second wedding anniversary. Pam is ... “Care, Support & ALS,” that’s part of ...
(Date:9/30/2014)... Neuromuscular and central nervous system ... States and worldwide. It is estimated that 50,000-60,000 ... year, adding to the more than one million ... people in the US are affected by Multiple ... statistics the 2.4 percent of the US population ...
Breaking Medicine News(10 mins):Health News:Rising Consumption of Meat and Meat Products to Fuel Growth in the Global Feed Acidifiers Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Consumption of Meat and Meat Products to Fuel Growth in the Global Feed Acidifiers Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Dietary polyunsaturated fatty acids linked to smaller risk of coronary heart disease 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 3
... Research, Inc.,(Scimitar) issues a review of StatSure Diagnostic ... for Investors Seeking,to Participate In a Proprietary Point-of-Care ... website: http://www.scimitarequity.com . ABOUT STATSURE ... development,manufacture and marketing of rapid immunoassay tests for ...
... Valve Repair Product Portfolio, MINNEAPOLIS, Oct. ... ), manufacturer and marketer of state-of-the-art cardiac,surgery ... and Drug,Administration (FDA) clearance for the ATS ... the next in a series of,mitral valve ...
... to Provide Funding and Support for "Patient Navigator,Program" ... Everett, Washington, EVERETT, Wash., Oct. 25 ... new Patient Navigator Program at,the Providence Regional Cancer ... one part of a strategic nationwide effort to,significantly ...
... for interviews, OAKLAND, Calif., Oct. 25 ... volunteer,registered nurses through its Registered Nurse Response Network ... the spreading disaster,created by wildfires in the region. ... to shelters in San Diego,County in response to ...
... House Republican Whip,Roy Blunt (Mo.) issued the following ... children,s health program created by,Republicans to expand taxpayer-funded care ... in some cases, not even in this country legally:, ... take our concerns to heart and,come back with an ...
... 25 Darwin,Professional Underwriters, Inc. (Darwin) (NYSE: ... its third quarter 2007 financial results following the,close ... conference call to,discuss the company,s third quarter 2007 ... 2007 at 8:00 a.m. Eastern Time. (Logo: ...
Cached Medicine News:Health News:StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) Review Issued By Scimitar Equity Research, Inc. 2Health News:ATS Medical Receives FDA Clearance for ATS Simulus Semi-Rigid Annuloplasty Ring 2Health News:ATS Medical Receives FDA Clearance for ATS Simulus Semi-Rigid Annuloplasty Ring 3Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 2Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 3Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 4Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 5Health News:CNA/NNOC Nurse Volunteers Deployed to Southern California Firestorm 2Health News:Darwin to Announce Third Quarter 2007 Financial Results 2
(Date:9/30/2014)... , Sept. 30, 2014 Headquartered in ... GWPC) is a diversified company comprised of several specialized ... advanced technology and the proven expertise of its team ... and wellness. WholeHealth Products, line of more than 10 ... centers, and its more than 8 retail consumer tests ...
(Date:9/30/2014)... N.Y. , Sept. 30, 2014  Millennium ... Millennium Medical Devices, has executed a sales, marketing ... Florida based provider of ... Accountable Care Organizations (ACOs) and hospitals through a ... serves over 10,400 active Physician Purchasing Accounts that ...
(Date:9/30/2014)...  The Corporate Whistleblower Center is urging ER ... 866-714-6466 if they have well documented proof of ... been sent home, as an intentional way to ... as the Center would like to explain. ... Photo - http://photos.prnewswire.com/prnh/20140929/149017 ...
Breaking Medicine Technology:WholeHealth Products Announces The Discovery Of The "Autism And Fragile X" Microwell And Rapid Diagnostic Test 2Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement 2Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 2Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 4
... 16 The board of directors of Intarcia Therapeutics, ... Kurt Graves as executive chairman of the board. In ... leadership to the board and work closely with management ... development with its potential blockbuster asset, ITCA 650 (DUROS® ...
... ONXX ) today announced that it will present ... 22, 2010 at 3:00 p.m. Eastern Time (12:00 p.m. Pacific ... of the presentation on our website at: ... on 15 minutes early in order to register and download ...
Cached Medicine Technology:Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals 2Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals 3Onyx Pharmaceuticals to Present at the UBS Global Life Sciences Conference 2
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal ... 20-200 ... 1.0~2.0 Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: